Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
about
Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
description
clinical trial
@en
klinisch onderzoek
@nl
name
Tolvaptan Phase 3 Efficacy and ...... ycystic Kidney Disease (ADPKD)
@en
type
label
Tolvaptan Phase 3 Efficacy and ...... ycystic Kidney Disease (ADPKD)
@en
prefLabel
Tolvaptan Phase 3 Efficacy and ...... ycystic Kidney Disease (ADPKD)
@en
P17
P6153
P1132
P1476
A Phase 3, Multi-center, Doubl ...... nant Polycystic Kidney Disease
@en
P17
P1813
TEMPO3:4
@en
P3098
NCT00428948
P580
2007-01-01T00:00:00Z
P582
2012-01-01T00:00:00Z